Search

Search bills, members, committees and pages...

Sign In

SARAH DURR

PreviousNext

44 federal lobbying filings, 2023 to 2026.

SARAH DURR is a registered lobbyist named on 44 federal lobbying filings, 2023 to 2026, reporting $1.4M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 they have filed under, by filings.

RegistrantFilingsReported
PUBLIC STRATEGIES WASHINGTON, INC.30$1.4M
NOVARTIS14—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$5.3M
20256—$10.3M
20244—$6M
202332$1.4M$1.8M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
TAXTaxation/Internal Revenue Code38
TRDTrade (domestic/foreign)26
BUDBudget/Appropriations22
MMMMedicare/Medicaid20
LBRLabor Issues/Antitrust/Workplace17
CPTCopyright/Patent/Trademark14
HCRHealth Issues14
RETRetirement9
CSPConsumer Issues/Safety/Products6
FINFinancial Institutions/Investments/Securities6
AVIAviation/Airlines/Airports5
AUTAutomotive Industry4
AGRAgriculture3
INSInsurance3
DEFDefense2
SCIScience/Technology2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act8
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…8
H.R. 1672Maintaining Investments in New Innovation Act8
H.R. 2214DRUG Act8
H.R. 2425Kairo Act of 20258
H.R. 946ORPHAN Cures Act8
H.R. 950Saving Seniors Money on Prescriptions Act8
S. 1041Affordable Prescriptions for Patients Act8
S. 1095Stop STALLING Act8
S. 1096Preserve Access to Affordable Generics and Biosimilars Act8
S. 1097Interagency Patent Coordination and Improvement Act of 20258
S. 832EPIC Act of 20258
S. 864HELP Copays Act8
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.7
H.R. 3037Access to Breast Cancer Diagnosis Act of 20257
H.R. 3152Patent Eligibility Restoration Act of 20257
H.R. 3160PREVAIL Act7
H.R. 3269ETHIC Act7
S. 1500Access to Breast Cancer Diagnosis Act of 20257
S. 43Skinny Labels, Big Savings Act7
H.R. 5256340B ACCESS Act5
S. 2276ETHIC Act5
S. 932Give Kids a Chance Act of 20255
H.R. 5371Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…3
S. 1682Alex Gate Safety Act of 20253

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
NOVARTISNOVARTIS2026 second_quarter$1.4MJul 20, 2026
NOVARTISNOVARTIS2026 first_quarter$3.9MApr 20, 2026
NOVARTISNOVARTIS2025 third_quarter$1.7MMar 9, 2026
NOVARTISNOVARTIS2025 second_quarter$920KMar 9, 2026
NOVARTISNOVARTIS2025 fourth_quarter$1MJan 20, 2026
NATIONAL AUTOMOBILE DEALERS ASSOCIATIONPUBLIC STRATEGIES WASHINGTON, INC.2023 fourth_quarter$50KOct 24, 2025
NOVARTISNOVARTIS2025 third_quarter$1.6MOct 20, 2025
NOVARTISNOVARTIS2025 second_quarter$880KJul 21, 2025
NOVARTISNOVARTIS2025 first_quarter$4.2MApr 21, 2025
NOVARTISNOVARTIS2024 fourth_quarter$720KJan 21, 2025
NOVARTISNOVARTIS2023 fourth_quarter$960KOct 21, 2024
NOVARTISNOVARTIS2024 third_quarter$740KOct 21, 2024
NOVARTISNOVARTIS2024 second_quarter$1MJul 22, 2024
NOVARTISNOVARTIS2024 first_quarter$3.5MApr 19, 2024
NOVARTISNOVARTIS2023 fourth_quarter$860KJan 22, 2024
SOUTHWEST AIRLINESPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$50KOct 20, 2023
PRUDENTIAL FINANCIAL INCPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$50KOct 20, 2023
PRINCIPAL FINANCIAL GROUPPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$30KOct 20, 2023
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$50KOct 20, 2023
NATIONAL CONFECTIONERS ASSOCIATIONPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$40KOct 20, 2023
NATIONAL AUTOMOBILE DEALERS ASSOCIATIONPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$50KOct 20, 2023
INVESTMENT COMPANY INSTITUTEPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$30KOct 20, 2023
BIOTECHNOLOGY INDUSTRY ORGANIZATIONPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$60KOct 20, 2023
ANHEUSER-BUSCH COMPANIES INCPUBLIC STRATEGIES WASHINGTON, INC.2023 third_quarter$70KOct 20, 2023
SOUTHWEST AIRLINESPUBLIC STRATEGIES WASHINGTON, INC.2023 second_quarter$50KJul 19, 2023